Nestle: No Need To Renegotiate Alcon Terms With Novartis
June 29 2009 - 11:20AM
Dow Jones News
Nestle SA (NESN.VX) said Monday it sees no reason to renegotiate
deal terms on eyecare company Alcon Inc. (ACL) with Swiss drugmaker
Novartis AG (NVS).
"We firmly believe the business continues to deliver excellent
results and therefore there is no need to renegotiate any
contractual terms of the agreement," James Singh said at an
investor event.
Singh is Nestle's head of finance and control.
Company Web site: www.nestle.com
-By Katharina Bart, Dow Jones Newswires; +41 43 443 8043;
katharina.bart@dowjones.com